A novel 4-(1,3,4-thiadiazole-2-ylthio)pyrimidine derivative inhibits cell proliferation by suppressing the MEK/ERK signaling pathway in colorectal cancer

A novel 4-(1,3,4-thiadiazole-2-ylthio)pyrimidine derivative inhibits cell proliferation by suppressing the MEK/ERK signaling pathway in colorectal cancer

Colorectal cancer (CRC) is one of the most common types of malignant cancers worldwide. Although molecularly targeted therapies have significantly improved treatment outcomes, most of these target inhibitors are resistant. Novel inhibitors as potential anticancer drug candidates are still needed to...

Full description

Bibliographic Details
Main Authors: Li Weiwei, Yang Zhifu, Ding Likun, Wang Ying, Zhao Xian, Chu Jian Jie, Ji Qing, Yao Minna, Wang Jingwen
Format: Article
Language:English
Published: Sciendo 2023-09-01
Series:Acta Pharmaceutica
Subjects:
colorectal cancer
proliferation
apoptosis
meta-stasis
mek/erk signaling pathway
Online Access:https://doi.org/10.2478/acph-2023-0025

Internet

https://doi.org/10.2478/acph-2023-0025

Similar Items